Results 261 to 270 of about 1,955,627 (332)

Reproductive aging, preimplantation genetic testing for aneuploidy, and the diameter of blastocysts: does size matter? [PDF]

Aging (Albany NY)
Wyroba J, Kochan J, Barszcz M, Mirocki G, Kordowitzki P.   +4 more
europepmc   +1 more source

MicroRNAs in seminal plasma are able to discern infertile men at increased risk of developing testicular cancer

Molecular Oncology, Volume 19, Issue 4, Page 1188-1202, April 2025.
Male infertility is a known risk factor for the development of testicular cancer. In this paper, we analyzed the expression profile of a microRNA panel by real‐time PCR and validated the results by digital PCR. Experimental and bioinformatics analyses allowed us to identify possible biomarkers able to discern men with a higher risk of developing ...
Carmen Ferrara, Rosalia Battaglia, Angela Caponnetto, Anna Fazzio, Michele Stella, Cristina Barbagallo, Nicolò Musso, Federica Lunelio, Maria Elena Vento, Placido Borzì, Paolo Scollo, Davide Barbagallo, Marco Ragusa, Salvatore Pernagallo, Cinzia Di Pietro   +14 more
wiley   +1 more source

For early diagnosis of young patients with Werner syndrome: Indication for genetic testing. [PDF]

Geriatr Gerontol Int
Sato T, Maezawa Y, Kato H, Shoji M, Maeda Y, Kaneko H, Aono K, Kubota Y, Taniguchi T, Oshitari T, Motegi SI, Takami Y, Nakagami H, Taniguchi A, Watanabe K, Takemoto M, Koshizaka M, Kosaki R, Matsuo M, Kaneko H, Ihara K, Oshima J, Yokote K, Japan Ministry of Health, Labor and Welfare Research Project for Intractable Diseases, Genetic Progeroid Syndrome Research Group.   +25 more
europepmc   +1 more source

Impact of molecular diagnostics and targeted cancer therapy on patient outcomes (MODIFY): a retrospective study of the implementation of precision oncology

Molecular Oncology, Volume 19, Issue 5, Page 1508-1516, May 2025.
The authors conducted a retrospective study of 94 patients with advanced cancer who underwent next‐generation sequencing (NGS) gene panel analysis and received targeted treatments when applicable. Results further support evidence indicating that molecular profiling provides clinical benefit.
Michaël Dang, Anna Schritz, Nikolai Goncharenko, Guy Berchem   +3 more
wiley   +1 more source

Early diagnosis of hereditary angioedema in children: genetic testing should be prioritized. [PDF]

Allergy Asthma Clin Immunol
Bocquet A, Pagnier A, Boccon-Gibod I, Defendi F, Dumestre-Perard C, Hardy G, Bouillet L.   +6 more
europepmc   +1 more source

Detection rate for ESR1 mutations is higher in circulating‐tumor‐cell‐derived genomic DNA than in paired plasma cell‐free DNA samples as revealed by ddPCR

Molecular Oncology, EarlyView.
Analysis of ESR1 mutations in plasma cell‐free DNA (cfDNA) is highly important for the selection of treatment in patients with breast cancer. Using multiplex‐ddPCR and identical blood draws, we investigated whether circulating tumor cells (CTCs) and cfDNA provide similar or complementary information for ESR1 mutations.
Stavroula Smilkou, Aliki Ntzifa, Victoria Tserpeli, Ioanna Balgkouranidou, Alkistis Papatheodoridi, Evangelia Razis, Helena Linardou, Christos Papadimitriou, Amanda Psyrri, Flora Zagouri, Stylianos Kakolyris, Evi Lianidou   +11 more
wiley   +1 more source

Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis

Molecular Oncology, Volume 19, Issue 4, Page 1002-1028, April 2025.
Using a mouse model that recapitulates the spread of tumor cells within the body, we have profiled paired tumors and metastasis samples using a multiomics approach combining different layers of biological information. We identified key genes that drive metastasis in Ewing sarcoma.
Mariona Chicón‐Bosch, Sara Sánchez‐Serra, Marta Rosàs‐Lapeña, Nicolás Costa‐Fraga, Judit Besalú‐Velázquez, Janet Illa‐Bernadí, Silvia Mateo‐Lozano, Florencia Cidre‐Aranaz, Thomas G.P. Grünewald, Ángel Díaz‐Lagares, Roser Lopez‐Alemany, Òscar M. Tirado   +11 more
wiley   +1 more source

Cross-border genetic testing

Orphanet Journal of Rare Diseases, 2010
Barton David
doaj   +1 more source

Navigating Genetic Testing in Nephrology: Options and Decision-Making Strategies. [PDF]

Kidney Int Rep
Groopman E, Milo Rasouly H.
europepmc   +1 more source